Podcasts about approvals

See omnystudio.com/listener for privacy information.

What do you get when you combine razor-sharp humour, social-first instincts, and a refusal to play by the rules?An equal-parts entertaining, and practical, deep dive into brand building on social today.This week, Verity sits down with Gabriel Gomez (Head of Social & Community @ MCoBeauty (US), Creator & Speaker) to explore how one of Australia's most-followed beauty brands is winning the US market. Spoiler alert: it's by moving fast, listening closely, and making the right kind of noise online.Turn this episode on and up to learn how to:Spot and Scale the Right Cultural Moments, Without 10 Approvals & a Deck: Gabe shares how MCoBeauty gets from idea to action in minutes, thanks to lean teams, shared instincts, and a refusal to overthink the feed.Build Campaigns with Cross-Functional Input (Without Slowing Things Down): Gabe's approach flips the usual script: involve people early, keep ideas fluid, and trust that great strategy can come from any level of the org.Choose Creators Based on Connection, Not Clout: Whether it's scouting emerging talent or inviting creators into the concepting process, Gabe breaks down how MCoBeauty treats creators like consultants, not content machines.Balance Viral Chaos with Brand Clarity (and Still Forget the Playbook): Social's a sprint, but that doesn't mean strategy gets lost. Learn how MCo blends brand consistency with bold, off-script moves that actually land.Build a Fast-Moving, Emoji-Powered Social Culture that Thrives Under Pressure: From skipping the decks to celebrating team wins with emphasis, Gabe shows how to lead a social team that runs on energy and impact.Decide What's a Green Flag (and What's a Giant Red One): In a rapid-fire game, Gabe shares exactly how he filters pitches, rates brand behaviour, and why he's definitely deleting your “$50 and a lipstick” offer.Plus: you'll hear why TikTok is their #1 Advocacy driver, how Gabe spots red-flag creators, and the surprising platform he opens first every day.His advice is fast, fresh, and unapologetically honest – just like the brands that win on social now.Chapters00:00 – Gabe Gomez & the MCoBeauty Mindset03:00 – Why Dupes, Not Decks, Drive Beauty Culture Now07:00 – Crashing Trends & Creating Chaos: Moving at the Speed of Social12:00 – F*** the Playbook: Balancing Strategy with Spontaneity17:00 – Creators as Consultants: Rethinking Influence & Partnerships22:00 – The Green Flag / Red Flag Game: What Brands Get Wrong (and Right)32:00 – Why TikTok's Driving Advocacy, And Instagram Isn't36:00 – The Platform Breakdown: What's Working, What's Next41:00 – How to Really Build Brand Advocacy (It's Not a Coupon Code)Rate & review Building Brand Advocacy:Apple PodcastsSpotifyConnect with Gabe:On LinkedInOn MCoBeauty's Instagram (US)

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has rejected Capricor's therapy for Duchenne Muscular Dystrophy (DMD), causing shares to plunge due to insufficient evidence of effectiveness for cardiomyopathy associated with DMD. Lilly and Sarepta also received Complete Response Letters (CRLs) for their therapies. Moderna has won full approval for its COVID-19 vaccine for higher-risk kids, while Pacira has cut staff in San Diego. The FDA has released a cache of CRLs, providing insights into the journeys to market for various drugs. AbbVie has acquired Ichnos Glenmark's lead myeloma antibody, and Ultragenyx's stock plummeted after a late-stage trial disappointment. Kennedy postponed a preventive care panel meeting after a Supreme Court win. Transitioning from one piece of news to the next, let's move on to the webinar exploring digitization strategies for drug development. Stay tuned for more updates in the pharmaceutical industry.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Kalvista has received approval for the first on-demand hereditary angioedema pill after facing challenges with the FDA. Meanwhile, Robert F. Kennedy Jr. has made significant cuts and rehires at the Department of Health and Human Services. Upcoming biopharma milestones to watch include developments in obesity and rare genetic diseases, as well as therapies targeting the TIGIT space. Drug developers are exploring digitization strategies to optimize processes and embrace technology in the development journey amidst a busy buyout period in the pharmaceutical industry.Transitioning to the next news, the text discusses four therapies targeting TIGIT that are still holding on in a troubled space where many others have failed. It also highlights the potential of using AI and genetics to reduce adverse drug reactions and restore public trust in the pharmaceutical industry. Additionally, it mentions the FDA's decision to remove risk evaluation and mitigation strategies for certain cell and gene therapies, as well as recent developments in ultrarare therapies, cancer treatments, and regulatory changes. The text provides information on the HHS overhaul by the numbers, including rehiring hundreds of employees but still operating with reduced staff.

Two Enterprise Ireland-backed companies have won funding approvals of up to €18.75m in the latest competition under Horizon Europe's European Innovation Council (EIC) Accelerator Programme. The two successful companies are CroíValve and Lios. Enterprise Ireland leads the National Support Network for Horizon Europe which helps entrepreneurs to compete and win funding in EIC competitions. To date, 28 Irish companies have secured approvals totalling €175.5m under the EIC Accelerator Programme since the beginning of Horizon Europe in 2021. Trinity College Dublin spin-out company CroíValve is a clinical-stage medical device company focused on developing a minimally invasive device for the treatment of a severe cardiac disease called tricuspid regurgitation. CroíValve's DUO Tricuspid Coaptation Valve system will enable a non-surgical solution for the condition as currently less than one percent of elderly patients receive surgical treatment due to the risks involved in this population. CroíValve previously received funding under the Disruptive Technologies Innovation Fund which is administered by Enterprise Ireland and supports research collaboration to drive disruptive technology development. Lios, a pioneer in acoustic advanced materials technology, is a Dublin company with strong Sligo roots. SoundBounce is an advanced acoustic material developed by Lios that works better than traditional sound dampening materials. Transport, home appliances, power generation, and construction are among the major industries seeking to reduce noise levels. Part of the EU's Horizon Europe 2021-2027 Research and Innovation Programme, the EIC Accelerator Programme provides transformational funding to high-potential, high-risk start-ups, scale-ups and SMEs. Approvals include grant funding of up to €2.5 million combined with an equity investment ranging from €0.5 to €10 million in a blended finance offer. 959 applications were submitted to this latest competition with 150 companies subsequently selected for interview resulting in a total of 40 funding awards to 16 countries. The 40 companies were allocated funding of up to €229m in a combination of grants and equity investments. Almost one third of the selected companies were led by a woman in a key leadership role such as CEO, CTO or CSO. Minister of State for Trade Promotion, AI and Digital Transformation Niamh Smyth TD said: "Today's announcement is testament to the research and innovation capability of Irish companies and the vibrancy of the start-up and commercialisation eco-system. Collaboration between Higher Education, state agencies, investors, and business creates a pathway to success, and the government, through Enterprise Ireland, is committed to helping enterprises like Lios and CroíValve to realise their commercial potential. This announcement provides significant funding to support these companies to bring their innovations to the global market, and I wish both every success for the future." Jenny Melia, CEO Designate, Enterprise Ireland, said: "I'd like to congratulate Lios and CroíValve on their successful applications to the highly competitive EIC Accelerator programme. Both companies, working with the EIC, will be able to enhance their entrepreneurial capability and get the critical support required at this juncture in their development and scaling journey. It is particularly welcome to see that both projects have a female-inclusive leadership team which supports Enterprise Ireland's strategic ambition to increase the participation of women in entrepreneurship and business leadership." Lucy O'Keeffe, Co-Founder & CEO, CroíValve said: "Securing European Innovation Council (EIC) funding is very impactful in supporting full alignment of our novel technology with this complex patient population, along with expansion of clinical validation of our DUO System. There is a real unmet clinical need to provide a scalable treatment option for the heterogeneous patient population with tricuspi...

Top tips on how to secure a mortgage as approvals hit record levels. Telling us all was Martina Hennessy, Managing Director of Doddl.

Senior reporter Richard Rennie unpacks Bayer Crop Science's exit from New Zealand. He says the exit highlights significant challenges in NZ's agricultural sector, particularly regarding the slow approval rates for new agri-chemical products, which hinders local trials critical for product approval.He also tells Bryan about challenges faced by catchment groups, which are crucial for addressing local farming issues. 

Ram Ramdas, Founder & Chief Evangelist, Wonderlend HubsWonderLend Hubs offers scalable, customisable solutions that adapt to the dynamic needs of modern lenders. It is a no-code, micro-modular solution delivered as a PaaS (Platform-as-a-Service) model. Modular architecture or microservices allows the company to offer ‘Micro plans', i.e. API bundles which are fully business user-configurable. Robin Amlôt of IBS Intelligence speaks to Ram Ramdas, Founder and Chief Evangelist at Wonderlend Hubs. 

Frustrated by slow development approvals?In this episode, Nathan Battishall reveals five actionable hacks to accelerate your Complying Development Certificate (CDC) process. What are the critical early steps you might be overlooking that could save you weeks?Nathan shares his expert insights on everything from early site assessments to strategic consultant engagement. Discover how to navigate the CDC pathway with greater efficiency and less stress. Learn how to streamline your applications and unlock faster approval times. Tune in to make your next CDC experience a more efficient one!Topics: ✅ Site Constraints Early in the Process✅ Site Classification and Geotechnical Information✅ Council-Related Approvals (e.g., Section 138)✅ Early Consultant Engagement✅ Certifier Involvement from Start✅ Importance of Proactive Planning and Information GatheringConnect with Nathan:LinkedIn: https://www.linkedin.com/in/nathanbattishall/Website: https://duplexbuildingdesign.com/ Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The CDC has reinstated around 460 employees who were previously fired, with the rehired staff working on viral disease prevention efforts and sexual health testing labs. This comes amid protests and shake-ups at the agency, including the overhaul of the vaccine advisory committee. Experts are concerned about newly appointed members, some of whom are known anti-vaxxers, potentially relitigating recommendations. Sen. Bill Cassidy is being urged to step up in response to these concerns.In other news, NuVation has received FDA approval for its oral lung cancer drug, Biontech has acquired CureVac in a $1.25 billion all-stock deal, and RFK Jr. has named new CDC vaccine advisors following a "clean sweep." Additionally, InVitro Cell Research is focused on discovering interventions to slow aging and prevent age-related diseases and is hiring scientists. The newsletter also includes information on layoffs at Genentech and Vertex.RFK Jr. has named eight new members to the CDC vaccine committee, replacing the 17 members he removed earlier in the week. The new choices seem to align with Kennedy's anti-vaccine views, causing concern among analysts. The HHS secretary's decision to appoint these scientists has raised questions about the committee's future direction.

Join Infinity's Rachael Howlett and My Housing Market's Dr. Andrew Wilson for all the latest movement in the Australian market.Weekly Property Market Update is presented to you by Infinity in conjunction with Australia's leading Independent Chief Economist, Dr Andrew Wilson of My Housing Market. Discover Our New Tool: What's My Rental Home Yield?Money Mentor YouTube Channel: @moneymentorau Link to Dr Andrew Wilson on LinkedIn: linkedin.com/in/dr-andrew-wilson-79b70058/If you enjoyed our Podcast, make sure you hit the FOLLOW button to stay up to date with the latest episodes. We really appreciate you supporting our podcast.

Our lead story: Ontario controversially passes Bill 5—sharply opposed by some First Nations—legislation which will enable the creation of special economic zones where provincial and municipal laws can be suspended to speed up approvals for mining projects like the Ring of Fire.

On episode 844 of WHAT THE TRUCK?!? Dooner is catching up with SearchCarrier's Garrett Allen. His new site allows you to easily look up any carrier and see how often it's been put out of service, inspected and more. We're also diving into his blitz week dashboard to break down this year's top violations. Konexial's Jerry D'Addesi on the latest in AI load matching, double broker prevention and edge computing. Is the FMCSA starting to take freight fraud more seriously? After FMCSA's identity verification became mandatory in April 2025, published authority counts dropped by over 50%. We'll take a look at the numbers.  And in headlines: tariffs on, tariffs off; fast food restaurants vs fleet sizes; excessive LEGO sets and more.  Chapters 3:04 New authority approvals down 50% 5:19 Tariffs on, tariffs off, tariffs on 8:16 Fleet sizes vs. fast food restaurant locations 10:52 Konexial | Jerry D'Addesi 16:54 FreightTech innovations | Jerry D'Addesi 20:15 Too much LEGO 22:40 SearchCarriers | Garrett Allen 27:41 Blitz week breakdown | Garrett Allen Catch new shows live at noon EDT Mondays, Wednesdays and Fridays on FreightWaves LinkedIn, Facebook, X or YouTube, or on demand by looking up WHAT THE TRUCK?!? on your favorite podcast player and at 5 p.m. Eastern on SiriusXM's Road Dog Trucking Channel 146. Watch on YouTube Check out the WTT merch store Visit our sponsor Subscribe to the WTT newsletter Apple Podcasts Spotify More FreightWaves Podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

On episode 844 of WHAT THE TRUCK?!? Dooner is catching up with SearchCarrier's Garrett Allen. His new site allows you to easily look up any carrier and see how often it's been put out of service, inspected and more. We're also diving into his blitz week dashboard to break down this year's top violations. Konexial's Jerry D'Addesi on the latest in AI load matching, double broker prevention and edge computing. Is the FMCSA starting to take freight fraud more seriously? After FMCSA's identity verification became mandatory in April 2025, published authority counts dropped by over 50%. We'll take a look at the numbers.  And in headlines: tariffs on, tariffs off; fast food restaurants vs fleet sizes; excessive LEGO sets and more.  Chapters 3:04 New authority approvals down 50% 5:19 Tariffs on, tariffs off, tariffs on 8:16 Fleet sizes vs. fast food restaurant locations 10:52 Konexial | Jerry D'Addesi 16:54 FreightTech innovations | Jerry D'Addesi 20:15 Too much LEGO 22:40 SearchCarriers | Garrett Allen 27:41 Blitz week breakdown | Garrett Allen Catch new shows live at noon EDT Mondays, Wednesdays and Fridays on FreightWaves LinkedIn, Facebook, X or YouTube, or on demand by looking up WHAT THE TRUCK?!? on your favorite podcast player and at 5 p.m. Eastern on SiriusXM's Road Dog Trucking Channel 146. Watch on YouTube Check out the WTT merch store Visit our sponsor Subscribe to the WTT newsletter Apple Podcasts Spotify More FreightWaves Podcasts Learn more about your ad choices. Visit megaphone.fm/adchoices

Mortgage approvals continued to grow in April as first-time buyer activity reached new highs, that's according to latest figures from the Banking and Payments Federation Ireland.Chief Economist at the BPFI, Ali Ugur joined Emmet to discuss these figures .

There's changes happening in the construction sector. Construction Minister Chris Penk is launching the country's first fully independent residential building consent authority - with approval subject to certain conditions being met. The privately-owned company, supported by the government, promises to issue building consents within 10 working days for eligible residential projects. Penk told Mike Hosking it's another option alongside local councils. He says initially it will be too small to take on all the work council does, but it might be able to scale up depending on what the appetite is. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Been wondering how some developers just seem to SPOT great property development opportunities?In this episode, host Nathan Battishall unpacks the "Potential Spotter" mindset. Learn how the last year has highlighted a key way of thinking that leads to success. Discover how to see potential others overlook.Nathan believes that spotting this potential isn't just a natural gift; it's a skill you can actually develop over time. If you're keen to identify more profitable deals, tune in to sharpen your ability to spot what truly matters in property development.Topics: ✅ Seeing Hidden Opportunities✅ Finding Value in Overlooked Sites✅ Learning and Research in Opportunity Spotting✅ Options, Approvals, and On-selling Potential✅ Finding Profit in Any Climate✅ Avoiding Emotional Investment in DealsConnect with Nathan:LinkedIn: https://www.linkedin.com/in/nathanbattishall/Website: https://duplexbuildingdesign.com/ Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.At a recent U.S. Senate hearing, Health and Human Services Secretary was questioned about cuts being made to the department and his stance on endorsing the measles vaccine during a growing outbreak. The hearing was tense at times, with RFK Jr. firm on supporting the cuts but wavering on his stance on the MMR vaccine. AbbVie's ADC received accelerated approval for lung cancer treatment, FDA delays decision on Biohaven's application, and chaos ensues at the FDA's advisory committee planning office after workforce cuts. Sino Biological offers solutions for autoimmune disease research, with reagents for nearly 50 diseases. Novo Nordisk has invested $2.4 billion in a new oral obesity drug through a deal with Septerna, aiming to catch up with competitors in the oral weight loss space. AbbVie has committed $335 million upfront in a partnership with Adarx Pharmaceuticals for siRNA research, while GSK has abandoned a TIGIT therapy and instead acquired rights to a liver drug from Boston Pharmaceuticals for potential $2 billion deal. This news highlights the ongoing developments and investments in the pharmaceutical industry.

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson's, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny. 

Relebogile Mabotja speaks to Michael Lenz the CEO of TransBridj about the TransBridj fully digitised, automated platform for attorneys, realtors, and property sellers offering fast-track approvals and disbursements within 24 hours to accelerate property transactions and unlock liquidity. 702 Afternoons with Relebogile Mabotja is broadcast live on Johannesburg based talk radio station 702 every weekday afternoon. Relebogile brings a lighter touch to some of the issues of the day as well as a mix of lifestyle topics and a peak into the worlds of entertainment and leisure. Thank you for listening to a 702 Afternoons with Relebogile Mabotja podcast. Listen live on Primedia+ weekdays from 13:00 to 15:00 (SA Time) to Afternoons with Relebogile Mabotja broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/2qKsEfu or find all the catch-up podcasts here https://buff.ly/DTykncj Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Dr. Jonathan Howard and Wendy Orent examine the alarming elevation of wellness influencer Casey Means as Surgeon General nominee, despite lacking a medical license or conventional medical credibility. They delve into Vinay Prasad's appointment as head of vaccine regulation, scrutinizing his past critiques of RCT deficiencies—and the impossible standards he now sets for himself. The episode also investigates the troubling rise of an autism registry, likened to authoritarian categorization, and NIH's internal collapse under Jay Bhattacharya, whose leadership is marked by mass layoffs and denial of responsibility. With science policy veering into cronyism, dismantling, and performative governance, the episode argues that we're witnessing a historic erosion of public health leadership—led not by scientists, but social media provocateurs. Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.  The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information. The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content. The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content. Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer. Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.

U.S. Ties Trade Pressure to Starlink Approvals in Push Against China

BUSINESS: Foreign borrowing approvals rise to P6.29B in Jan-March | April 28, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimesVisit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. In a recent interview with former Fox News journalist Megyn Kelly, FDA Commissioner Marty Makary discussed a potential new mechanism-driven pathway for expedited rare disease approvals, as well as the possibility of certain environmental factors contributing to autism. Despite Makary's announcement of a directive to limit industry participation in the FDA's advisory committees, industry involvement is actually required by a 1997 law, and banning industry representatives would not have a significant impact. Additionally, the FDA recently approved Sanofi/Regeneron's Dupixent for chronic hives after initially rejecting it, and Lilly has promised to manufacture a weight-loss pill in the US following a Phase III win. The newsletter also includes other news stories, opinions, and upcoming events in the biopharmaceutical industry.

In this episode, we're joined by Dave Hughes, PharmD, BCOP, MPH, Senior Medical Director at Pfizer, who shares his expertise on the clinical trial landscape. With years of experience in oncology research and clinical pharmacy, Dave breaks down the key phases of clinical trials—from early-stage safety assessments to confirming effectiveness in large populations. Understanding these phases is essential for anyone involved in the drug development process.Dave also delves into the growing role of real-world evidence, which offers valuable insights into how therapies perform in everyday clinical settings, complementing traditional clinical trial data. He discusses how FDA approval pathways, such as fast track, breakthrough therapy, and accelerated approval, are designed to expedite access to life-saving therapies.We also explore the future of clinical trials, from AI and machine learning's transformative impact on research to the evolving strategies that will shape patient care. Finally, Dave addresses the common misconception that clinical trials are only available as a last resort, emphasizing that they offer early access to cutting-edge treatments throughout a patient's journey. Disclaimer:The views and opinions expressed in this episode are solely those of our guest, Dave, and do not represent the official stance, policies, or views of Pfizer, NCODA, or any other organization. This discussion is for informational purposes only and should not be considered medical or regulatory advice. Always consult with regulatory authorities for official guidance.

FDA expands approvals for durvalumab (bladder cancer) and Lutetium-177 vipivotide tetraxetan (pre-taxane in metastatic prostate cancer). Portland has places.

// Merlin - SIGN UP FREE 30 DAY TRIAL https://tinyurl.com/MerlinGMCYouTube //// T H E 3 T W A R R I O R A C A D E M Y // Join the 3T Warrior Academy: https://3twarrior.com/warrioracademy?affiliate_id=3827481 // Join our Free Discord: https://3twarrior.com/discord49541345 //// F O L L O W T H E T E A M // Official Good Morning Crypto https://linktr.ee/3tGMCrypto Twitter: https://twitter.com/3tGMCrypto // Abs  Instagram: https://www.instagram.com/Abs3t/ Twitter: https://twitter.com/AbsGMCrypto // Johnny Krypto https://linktr.ee/johnnykrypto Twitter: https://twitter.com/JohnnyKrypto00 YouTube: https://www.youtube.com/channel/UCm-qyQNf1rnUaw6u20mKCVw // Gonzo Twitter: https://twitter.com/gonzo_3t Instagram: https://www.instagram.com/gonzo_3t/ // Mario https://marios.link Twitter: https://twitter.com/LinkWithMario Youtube: https://youtube.com/@LinkWithMario Instagram: https://www.instagram.com/LinkWithMario/ TikTok: https://www.tiktok.com/@LinkWithMario //// Disclaimer: All of our videos are strictly personal opinions. Please make sure to do your own research. Never take one person's opinion for financial guidance. There are multiple strategies and not all strategies fit all people. Our videos ARE NOT financial advice. We are not financial advisers & this is not financial advice. #Crypto #CryptoNews #Bitcoin #BTC #ethereum #eth #ripple #xrp #chainlink #quant #polygon #qnt #cardano #xlm #hbar #cspr #algo #algorand #cspr #Abs #JohnnyKrypto #GoodMorningCrypto #stellar #fednow #ada #digitalcurrency #digitalassets #tokenization #ada #hbar #hedera #usdc #usdt #jennax #ripplewin #xdc #xinfin #rippleceo #bradgarlinghouse #nft #nfts #xrppump #chainlinks #swift #tokenizedassets #xrpltokenization #uphold #coinbase #visa #fidelity #bitcoinetf #micklexrp #xrpmickle #mickle #ripplepartnership Learn more about your ad choices. Visit megaphone.fm/adchoices

New CSO stats show planning approvals for new apartments plummeted in 2024. We ask why with Conor O'Connell Director of Housing and Planning at the Construction Industry Federation of Ireland.

This quick hit episode is incredibly important for every Service Team! Ready to boost your service department's success?! Let's gooooo!  In this quick class, I lock in on the often-overlooked 'Risk & Reward' equation in the service sales process. Many Service Advisors hesitate to fully explain the risks of delaying necessary work, leading to missed opportunities and customer misunderstandings. We'll explore how presenting both the risks and rewards transparently can transform hesitant customers into loyal advocates who toss you their keys with confidence. Join me as I share real-world examples and strategies to help General Managers and leaders coach their teams effectively, boosting revenue and fostering trust. Discover how a simple shift in communication can lead to higher approval rates and a thriving dealership culture. This episode offers insights to elevate your sales presentations and ensure customers understand the true value of timely service. Tune in and learn how to make 'Risk & Reward' work for you and your team! Dealer Talk with Jen Suzuki Podcast |

Interview with Mark Selby, CEO of Canada NickelOur previous interview: https://www.cruxinvestor.com/posts/canada-nickel-tsxvcnc-historic-20m-first-nations-investment-6434Recording date: 2nd March 2025Canada Nickel Company has successfully completed Front-End Engineering Design (FEED) for its flagship Crawford Nickel Project, advancing engineering to approximately 30% completion. Despite a 5% increase in capital costs, the project has demonstrated improvements in Net Present Value (NPV) and Internal Rate of Return (IRR).In a strategic optimization move, the company modified its mine plan to prioritize the East Zone over the Main Zone. This decision reduces stripping requirements and truck fleet needs, which helps offset capital cost increases. CEO Mark Selby highlighted the company's efficient development approach, noting they've progressed from "fifth drill hole to feasibility study in just over four years," significantly faster than industry averages of 7-10 years.On the financing front, Canada Nickel has secured letters of intent for $500 million USD from Export Development Canada and $500 million CAD from another financial institution. The next step involves an independent engineering review to validate the company's work. Notably, Middle Eastern sovereign wealth funds are showing substantial interest in the project as they seek to diversify their economies beyond oil.Beyond Crawford, the company aims to establish the Timmins area as a premier nickel district. Plans include publishing resources for six additional properties, bringing their total to nine resources in the district. Selby claims the total nickel resource is expected to exceed "the total endowment at Sudbury, which was the world's largest nickel sulfide district."Community partnerships represent another significant advancement, with Canada Nickel announcing construction projects to be delivered by First Nations communities through a business vehicle called Wabun. This approach demonstrates local support and strengthens the company's social license as it progresses through permitting.The company remains on track with its permitting timeline, currently in the final approval stage with the federal government. Approvals are expected by year-end, with provincial permits to follow. Canada Nickel is also exploring non-equity financing options, including royalties, to minimize shareholder dilution.The Crawford project is positioned to become "the Western world's largest nickel sulfide operation" with the flexibility to serve both EV battery and stainless steel markets. This strategic positioning comes at a time when Western economies are actively seeking to reduce dependence on Chinese-dominated supply chains for critical minerals, potentially creating significant long-term value for the company and its investors.View Canada Nickel's company profile: https://www.cruxinvestor.com/companies/canada-nickelSign up for Crux Investor: https://cruxinvestor.com

Welcome to the CRE podcast. 100% Canadian, 100% commercial real estate. In this episode of Commercial Real Estate Podcast, hosts Adam Powadiuk and Aaron Cameron are joined by Jennifer Keesmaat, President and CEO of Collecdev-Markee,  to discuss Canada's housing development challenges. They explore inefficiencies in approval processes, vested interests that cause delays, and policy innovations... The post Revolutionizing Housing Approvals: Jennifer Keesmaat's Vision for Smarter Development appeared first on Commercial Real Estate Podcast.

The Government's hoping to clear up backlogs of approvals for animal and plant health products as it commits to speeding up processes. It's accepted all 16 Ministry of Regulation recommendations for cutting red tape in agriculture and horticulture. That follows last year's review, looking into processes for new veterinary medicines and agri-chemicals. Food Safety Minister Andrew Hoggard told Mike Hosking he knew of the concerns around delays before taking his current role. He admits seeing the processes and wait-times first-hand was an eye-opener. LISTEN ABOVE See omnystudio.com/listener for privacy information.

In this episode, we're tackling a major gap in dealership service departments—technician videos. These videos are a game-changer for gaining more work approvals, yet most technicians receive zero training on how to shoot them effectively. Data shows that shops using video can double RO sales, with TruVideo reporting a 20-30% increase in revenue per RO. But here's the problem—background noise, unclear explanations, and long-winded clips are costing you approvals and money. I've been training service advisors across the country on gaining approvals, mastering sales conversations, and improving call handling—and now, I'm bringing that same energy to technicians. In this episode, I break down: ✅ How to shoot clear, effective videos that set up approvals ✅ The power of credibility and a strong greeting ✅ Why short, engaging videos drive more customer trust ✅ The meaning of “extra extra” and how it leads to extra sales ✅ How to increase work, grow sales, and keep your shop busy This is a must-listen for service directors, fixed ops leaders, and dealership owners looking to boost customer trust, grow revenue, and help their teams hit their full income potential. Dealer Talk with Jen Suzuki Podcast |Jennifer@edealersolution.com | 800-625-1590 | edealersolutions.com | Meet me!  bit.ly/3J7011t  Check out my other show, Loyalty-Based Selling Strategies on CBT News | https://bit.ly/3JlcXAx

Wouldn't you agree that it is easier to win at a game when you know the rules? Today we are giving you the inside scoop for having the best strategy for getting your mortgage approved. You will get expert tips for better results on your home appraisal too.

New vaccines to protect against meningococcal disease and chikungunya virus; skin prep product recalled due to fungal contamination; rapid-acting insulin biosimilar approved; and twice-yearly lenacapavir gets FDA's priority review for HIV PrEP.

Today on our Midweek Mini, Mary Ellen is flying solo while Jo is out sick with the flu. In this episode, she dives deep into an essential topic: freezing your credit. With identity theft becoming more and more prevalent, freezing your credit is one of the simplest and most effective ways to protect yourself—and best of all, it's completely free!Mary Ellen takes you step by step through the process of freezing your credit with all three major bureaus, making it easy for anyone to do. She also explains how to temporarily “thaw” your credit when applying for a new card, so you can unlock the benefits without risking your security.To wrap things up, she shares some insider tips about how keeping certain bureaus frozen can actually improve your chances of qualifying for specific cards, especially if some of your scores are lower than others.Packed with practical advice, this episode is a must-listen for anyone in the points and miles community, or really anyone who wants to stay ahead in the fight against identity theft. Don't miss it!Facebook Group | Support the Show: Buy Us A CoffeeFind Us On InstagramMary Ellen | JoMentioned in this EpisodeFreeze Your ExperianFreeze Your TransUnionFreeze Your EquiFaxAffiliate LinksCredit Card Affiliate LinksThe above link includes referrals for almost all travel cards (AMEX, CapitalOne, co-branded cards)If you need Chase links please reach out! We would be happy to send you our personal referral links.Using our links is an amazing way to show your support for the show at no cost to you ❤️

Show notes 1. Jeremias S. A banner year for biosimilars: The 19 FDA approvals from 2024. The Center for Biosimilars. January 21, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/a-banner-year-for-biosimilars-the-18-fda-approvals-from-2024 2. Jeremias S. FDA approves Celltrion's Avtozma as third tocilizumab biosimilar. The Center for Biosimilars. January 31, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/fda-approves-celltrion-s-avtozma-as-third-tocilizumab-biosimilar 3. Jeremias S. Senators introduce bipartisan legislation to protect skinny labeling. The Center for Biosimilars. January 2, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/senators-introduce-bipartisan-legislation-to-protect-skinny-labeling 4. Jeremias S. FTC releases second report on PBMs meddling in generic drug markets. The Center for Biosimilars. January 19, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/ftc-releases-second-report-on-pbms-meddling-in-generic-drug-markets 5. Santoro C. Earlier patent litigation could accelerate US biosimilar market entry. The Center for Biosimilars. January 9, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/earlier-patent-litigation-could-accelerate-us-biosimilar-market-entry 6. Jeremias S. Welcome Wezlana: the first Stelara biosimilar to launch in the US. The Center for Biosimilars. January 31, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/welcome-wezlana-the-first-stelara-biosimilar-to-launch-in-the-us 7. Jeremias S, Chambers JD. The banking of biosimilars: insights from a leading health economist. The Center for Biosimilars. February 4, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/the-banking-of-biosimilars-insights-from-a-leading-health-economist 8. Jeremias S. The biosimilar void: 90% of biologics coming off patent will lack biosimilars. The Center for Biosimilars. February 5, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/the-biosimilar-void-90-of-biologics-coming-off-patent-will-lack-biosimilars 9. Jeremias S. Biosimilars drive cost savings and achieve 53% market share across treatment areas. The Center for Biosimilars. January 16, 2025. Accessed February 7, 2025. https://www.centerforbiosimilars.com/view/biosimilars-drive-cost-savings-and-achieve-53-market-share-across-treatment-areas

cuss the latest developments in the healthcare industry. They dive into the FDA's recent approval of Ozempic for chronic kidney disease, the soaring costs of GLP-1 medications, and the growing influence of Mark Cuban's Cost Plus Drug Company in hospital and pharmacy supply chains.

New drill results this morning from Midnight Sun Mining, Banyan Gold and Awale Resources. Calibre Mining published a mineral resource estimate for the Talavera Deposit. Alamos Gold has been granted approval of its permit amendment in Mexico. This episode of Mining Stock Daily is brought to you by...  Arizona Sonoran Copper Company (ASCU:TSX) is focused on developing its brownfield copper project on private land in Arizona. The Cactus Mine Project is located less than an hour's drive from the Phoenix International airport. Grid power and the Union Pacific Rail line situated at the base of the Cactus Project main road. With permitted water access, a streamlined permitting framework and infrastructure already in place, ASCU's Cactus Mine Project is a lower risk copper development project in the infrastructure-rich heartland of Arizona.For more information, please visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.arizonasonoran.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Vizsla Silver is focused on becoming one of the world's largest single-asset silver producers through the exploration and development of the 100% owned Panuco-Copala silver-gold district in Sinaloa, Mexico. The company consolidated this historic district in 2019 and has now completed over 325,000 meters of drilling. The company has the world's largest, undeveloped high-grade silver resource. Learn more at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠https://vizslasilvercorp.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Calibre Mining is a Canadian-listed, Americas focused, growing mid-tier gold producer with a strong pipeline of development and exploration opportunities across Newfoundland & Labrador in Canada, Nevada and Washington in the USA, and Nicaragua. With a strong balance sheet, a proven management team, strong operating cash flow, accretive development projects and district-scale exploration opportunities Calibre will unlock significant value. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.calibremining.com/⁠

57% of Startup Visa applications await eligibility review as Canada ramps up processing speed, clearing 5,633 cases in 2024.View the full article here.Subscribe to the IMI Daily newsletter here.

A new report finds a “staggering” number of buildings missing required permits, but the Turkish House was the only one of its size approved to open without a valid fire safety plan. Plus, the head of the Board of Elections is facing scrutiny after city investigators found he created a hostile work environment. Also, WNYC's Michael Hill and Liam Quigley look into the impact of New York City's congestion pricing program. And finally, a New York-based artist talks about healing and community through dance.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Katrina Fitten.  She is also the CEO and CFO of New Day For You Financial Services.  She is a national leader in business funding solutions. Katrina helps women business owners secure $100k in funding in 100 days or less, with same-day approvals and next-day funding.  Katrina's company empowers them to build financial empires. With a Bachelor's in Agricultural Economics, an Executive MBA, and 30 years of professional experience, she has facilitated over $1 million in funding this past year supporting a growing community of women entrepreneurs on their path to becoming first-generation millionaires. Recognized by ESSENCE Magazine and MSN, Fitten is committed to helping women revolutionize their relationship with money and gain confidence in their cash flow to achieve financial peace and generational wealth Talking Points/Questions What a wild time! What is your general take on money, finances post-election?Question 1: How might the proposed changes in the tax code affect small business owners, especially in terms of profit margins and tax write-offs?Question 2: How will Trump's probable proposal of increased tariffs impact mid-to-low income families and business owners?Question 3: How do you predict the potential impact on consumers and business owners if there is deportation enforcement of immigrants?Question 4: What are the implications of the ongoing discussions about Social Security benefits for everyday Americans?Question 5: How can listeners take proactive steps to navigate these financial uncertainties? #STRAW #BEST #SHMS  Support the show: https://www.steveharveyfm.com/See omnystudio.com/listener for privacy information.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Katrina Fitten.  She is also the CEO and CFO of New Day For You Financial Services.  She is a national leader in business funding solutions. Katrina helps women business owners secure $100k in funding in 100 days or less, with same-day approvals and next-day funding.  Katrina's company empowers them to build financial empires. With a Bachelor's in Agricultural Economics, an Executive MBA, and 30 years of professional experience, she has facilitated over $1 million in funding this past year supporting a growing community of women entrepreneurs on their path to becoming first-generation millionaires. Recognized by ESSENCE Magazine and MSN, Fitten is committed to helping women revolutionize their relationship with money and gain confidence in their cash flow to achieve financial peace and generational wealth Talking Points/Questions What a wild time! What is your general take on money, finances post-election?Question 1: How might the proposed changes in the tax code affect small business owners, especially in terms of profit margins and tax write-offs?Question 2: How will Trump's probable proposal of increased tariffs impact mid-to-low income families and business owners?Question 3: How do you predict the potential impact on consumers and business owners if there is deportation enforcement of immigrants?Question 4: What are the implications of the ongoing discussions about Social Security benefits for everyday Americans?Question 5: How can listeners take proactive steps to navigate these financial uncertainties? #STRAW #BEST #SHMS  See omnystudio.com/listener for privacy information.

Two-time Emmy and Three-time NAACP Image Award-winning, television Executive Producer Rushion McDonald interviewed Katrina Fitten.  She is also the CEO and CFO of New Day For You Financial Services.  She is a national leader in business funding solutions. Katrina helps women business owners secure $100k in funding in 100 days or less, with same-day approvals and next-day funding.  Katrina's company empowers them to build financial empires. With a Bachelor's in Agricultural Economics, an Executive MBA, and 30 years of professional experience, she has facilitated over $1 million in funding this past year supporting a growing community of women entrepreneurs on their path to becoming first-generation millionaires. Recognized by ESSENCE Magazine and MSN, Fitten is committed to helping women revolutionize their relationship with money and gain confidence in their cash flow to achieve financial peace and generational wealth Talking Points/Questions What a wild time! What is your general take on money, finances post-election?Question 1: How might the proposed changes in the tax code affect small business owners, especially in terms of profit margins and tax write-offs?Question 2: How will Trump's probable proposal of increased tariffs impact mid-to-low income families and business owners?Question 3: How do you predict the potential impact on consumers and business owners if there is deportation enforcement of immigrants?Question 4: What are the implications of the ongoing discussions about Social Security benefits for everyday Americans?Question 5: How can listeners take proactive steps to navigate these financial uncertainties? #STRAW #BEST #SHMS  See omnystudio.com/listener for privacy information.